Healthcare Equipment and Supplies
Company Overview of Singulex, Inc.
Singulex, Inc. develops and manufactures immunodiagnostic products. It provides immunoassay systems, which includes benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and software to automatically analyze data and display detailed assay reports. The company also offers molecule counting products; ultrasensitive immunoassays, such as inflammation, cardiovascular, neurology, oncology, metabolism, and toxicity; SgxHD for cardiovascular monitoring; and custom services and support, such as sample testing, assay development, and antibody derivatization. Singulex, Inc. was formerly known as BioProfile Corporation and changed its name to Singulex, ...
1650 Harbor Bay Parkway
Alameda, CA 94502
Founded in 1997
Key Executives for Singulex, Inc.
Chief Financial Officer and Principal Accounting Officer
Chief Commercial Officer and Senior Vice President of Sales & Marketing
Vice President of Business Development
Compensation as of Fiscal Year 2014.
Singulex, Inc. Key Developments
Singulex, Inc. Provides Development Progress with Ultrasensitive Sgx Clarity System
Jul 23 14
Singulex, Inc. outlined development progress toward commercializing, as early as 2016, an ultrasensitive immunoassay system for the in vitro diagnostics (IVD) market. Utilizing Singulex's proprietary SMC technology, the fully-automated Sgx Clarity System is designed to detect low abundance biomarkers at levels down to femtograms/mL. The company's novel immunochemistry technology will be introduced to the American Association for Clinical Chemistry at the Annual Meeting taking place in Chicago from July 27 to 31, 2014.
Singulex Appoints Peter Heseltine as Chief Medical Officer
May 21 14
Singulex, Inc. announced the appointment of Peter Heseltine, M.B., B.Ch., B.A.O., as Chief Medical Officer. At Singulex, Dr. Heseltine will have overall responsibility for clinical strategy, including scientific and medical affairs.
Sony DADC and Singulex Announce Strategic Partnership for Proprietary Detection Vessels
Mar 31 14
Sony DADC Austria AG and Singulex, Inc. announced an exclusive multi-year supply agreement covering customized detection vessels designed and manufactured by Sony DADC BioSciences for the Sgx Clarity(TM) System, an ultrasensitive in vitro diagnostics (IVD) platform currently in development. Utilizing Singulex's proprietary single molecule counting (SMC(TM)) technology, the fully-automated Sgx Clarity(TM) System is expected to detect low abundance biomarkers at levels down to femtograms/mL. The customized detection vessel is manufactured as a one-piece, molded microtiter plate that has high optical transparency, high purity and low fluorescence, all critical properties required for achieving the ultrasensitivity of the Sgx Clarity(TM) System. The detection vessel is manufactured in Sony's clean-room environment under ISO 13485 and specially packaged in order to maintain product integrity and maximize cleanliness.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|